Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Industrial Hygiene and Occupational Diseases ; (12): 461-465, 2015.
Artigo em Chinês | WPRIM | ID: wpr-350571

RESUMO

<p><b>OBJECTIVE</b>To analyze and summarize the characteristics and treatment of acute spinal cord decompression sickness. To explore the factors that influence the treatment effect.</p><p><b>METHODS</b>77 cases of acute spinal cord decompression sickness patients should be divided into 4 groups according to the pressurized treatment and drug treatment options. They were group I, group II, group III and group IV. At the same time they were get hyperbaric oxygen therapy and other treatment. The evaluation index, were Frankel function classification and paraplegia index. There were 17 factors that affected the treatment effect.</p><p><b>RESULTS</b>The rate of early cure was 57.14% (44/77). The rate of late cure was 74.03% (57/77). Their difference was statistically significant (P<0.05). In 3 months and 1 year the cure rate of group IV and group B were the highest. But there was no difference between them(P>0.05). They were higher than group ii and group I (P<0.05). The Frankel function classification in 3months and 1 year in each group was higher than before treatment (P<0.05). The paraplegia index in 3 months and 1 year in each group was lower than before treatment (P<0.05). In 3 months and 1 year the Frankel function classification was increased gradually and the paraplegia index was decreased gradually in group I , group II, group III (P<0.05). In group IV and group III the Frankel function and the paraplegia index had not significant difference (P>0.05). Among the 17 factors that affect the treatment effect there are 9 factors that affect the proportion of the large.</p><p><b>CONCLUSIONS</b>The first choice of treatment method for the patients with acute spinal cord decompression sickness would be group III. Drug therapy was also imporpant. At the same time the hyperbaric oxygen therapy and other treatments were taken. Although the cure rate was not high in this article. But most of the cure is within 3 months. Within 1 year.the cure rate still could be improved. 9 factors that affect the efficacy of acute spinal cord decompression sickness was more noteworthy.</p>


Assuntos
Humanos , Doença da Descompressão , Terapêutica , Mergulho , Oxigenoterapia Hiperbárica , Paraplegia , Terapêutica , Medula Espinal
2.
Chinese Journal of Physical Medicine and Rehabilitation ; (12): 362-366, 2011.
Artigo em Chinês | WPRIM | ID: wpr-412512

RESUMO

Objective To observe the changes of CD11 a, CD11c and CD54 and its' influence on prognosis after the intervention of hyperbaric oxygen(HBO) in patients with acute cerebral infarction (ACI).Methods Sixty-four ACI patients were divided into control group( C group) and HBO therapy group( HBOT group).C group (33 cases) received routine treatment only, HBOT group ( 31 cases) received routine treatment and hyperbaric oxygen therapy.CD 11 a, CD11 c and CD54 were measured in both groups at ≤72h, the 7th d, 10th d, 12th d, 20th d after ACI, and neural functional damage scores(NDS) were evaluated at the same time.CD11a, CDllc and CD54 were also measured in normal control group (25 cases).Results Plasma levels of CD11a, CD11c and CD54 rose significantly both in HBOT group and C group and peaked at≤72 h after ACI, there was no significant difference between two groups (P > 0.05), then declined at the 7th d.Levels of CD11 a, and CD11c maintained at the peak for 7 d in H BOT group and for 10 d in C group.CD54 peak remained for 10 d in HBOT group, and for 12 d in C group.A correlation analysis and linear regression analysis showed that the NDS levels at 20th d (short-term curative effect), 6 months and 12 months (long-term outcome) could be explained by 97.3 % , 96.7% and 96.6% , respectively by the admission levels of CD11 a and/or CD11 c and/or CD54 and other related factors.Conclusion After hyperbaric oxygen therapy peak level duration of CD11a, CD11c and CD54 could be shortened.Hyperbaric oxygen could influence intercellular adhesion molecule changing process, reduce leukocytes adhesion, decrease expressions of CD11a CD11c and CD54, and protect ACI patients.Before treatment, expression of CD11a, CD11c and CD54 may predict the severity, short or long-term outcome and prognosis of ACI patients.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA